Breaking News, Collaborations & Alliances

Precision NanoSystems, Replicate Bioscience Partner to Scale Up Genomic Medicines

PNI will provide lipid nanoparticle solutions for scale-up and manufacture of up to 15 Replicate srRNA therapeutics.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Precision NanoSystems (PNI) and Replicate Bioscience will enter a licensing agreement to accelerate the creation, scale-up, and delivery of self-replicating RNA (srRNA) therapies.   PNI is a provider of technologies, services, and solutions for the development of lipid nanoparticle genomic medicines and Replicate Bioscience pioneers ways to prevent drug resistance in cancer and to treat autoimmune and inflammatory disorders and other diseases using self-replicating RNA (srRNA). PNI will provid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters